Kelsey Mcmanus

Kelsey Mcmanus practices at Westchester Medical Center in Valhalla, New York, part of Westchester Medical Center Health Network.

Kelsey Mcmanus' NPI, 1558980623, was assigned on April 9, 2020. Kelsey Mcmanus holds New York license 323873.

Kelsey Mcmanus' primary practice is Westchester Medical Center, at 100 Woods Rd, Valhalla, NY 10595 in Westchester County. The practice phone is (914) 493-7000.

Kelsey Mcmanus' primary practice is Westchester Medical Center in Valhalla, New York, part of Westchester Medical Center Health Network. The medical group on file is Westchester Medical Center Advanced Physician Services.

Dmand AI tracks the electronic health record (EHR) system at each site where Kelsey Mcmanus practices. Vendor and product names are available with a free account.

Internal medicine is Kelsey Mcmanus' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Kelsey Mcmanus is licensed in New York.

CMS data shows 298 Medicare services from Kelsey Mcmanus across 4 procedure codes in 2024, for 94 Medicare patients. Medicare paid $23,406 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 94 Medicare patients who saw Kelsey Mcmanus in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

In 2024, Kelsey Mcmanus wrote 160 Medicare Part D claims for 31 patients. 77% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $62 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Kelsey Mcmanus for performance year 2024, reported as part of a group.

CMS Open Payments shows 16 general payments to Kelsey Mcmanus from 3 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $226.